We are live on
!
Find out more
AE
Axon Enterprise Portfolio holdings
AUM
$19.1M
1-Year Est. Return
8.75%
This Fund
S&P 500
This Quarter
Est. Return
-2.7%
1 Year Est. Return
-8.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$27.2M
AUM Growth
-$41M
(-60%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-143.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cellebrite
CLBT
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 100% |
Similar funds
LFA
BIMC
IACCGIA
PMAM
SRHG
VAM
FS
MPW
Axon Enterprise's Q4 2025 Portfolio in Review
As of Q4 2025, Axon Enterprise held 1 position worth $27.2M, down 60% from $68.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Axon Enterprise withdrew a net $39M in Q4 2025, reducing 1 holding. Its largest reduction was Cellebrite, cutting an estimated $39M.
By sector, the portfolio is most concentrated in Technology at 100% of assets, unchanged from a quarter earlier.
- Axon Enterprise's biggest Q4 2025 reduction was Cellebrite, cutting an estimated $39M.
- Axon Enterprise's ten largest holdings make up 100% of its $27.2M portfolio in Q4 2025.
- Axon Enterprise opened 0 new positions and closed 0 in Q4 2025.
- Axon Enterprise's portfolio value fell 60% quarter-over-quarter to $27.2M.
Based on Axon Enterprise's 13F filing for Q4 2025, filed 17 Feb 2026.